» Articles » PMID: 29896314

Mental Stress As Consequence and Cause of Vision Loss: the Dawn of Psychosomatic Ophthalmology for Preventive and Personalized Medicine

Overview
Journal EPMA J
Date 2018 Jun 14
PMID 29896314
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

The loss of vision after damage to the retina, optic nerve, or brain has often grave consequences in everyday life such as problems with recognizing faces, reading, or mobility. Because vision loss is considered to be irreversible and often progressive, patients experience continuous mental stress due to worries, anxiety, or fear with secondary consequences such as depression and social isolation. While prolonged mental stress is clearly a of vision loss, it may also aggravate the situation. In fact, continuous stress and elevated cortisol levels negatively impact the eye and brain due to autonomous nervous system (sympathetic) imbalance and vascular dysregulation; hence stress may also be one of the major of visual system diseases such as glaucoma and optic neuropathy. Although stress is a known risk factor, its causal role in the development or progression of certain visual system disorders is not widely appreciated. This review of the literature discusses the relationship of stress and ophthalmological diseases. We conclude that stress is both and of vision loss. This creates a vicious cycle of a downward spiral, in which initial vision loss creates stress which further accelerates vision loss, creating even more stress and so forth. This new psychosomatic perspective has several implications for clinical practice. Firstly, stress reduction and relaxation techniques (e.g., meditation, autogenic training, stress management training, and psychotherapy to learn to cope) should be recommended not only as complementary to traditional treatments of vision loss but possibly as preventive means to reduce progression of vision loss. Secondly, doctors should try their best to inculcate positivity and optimism in their patients while giving them the information the patients are entitled to, especially regarding the important value of stress reduction. In this way, the vicious cycle could be interrupted. More clinical studies are now needed to confirm the causal role of stress in different low vision diseases to evaluate the efficacy of different anti-stress therapies for preventing progression and improving vision recovery and restoration in randomized trials as a foundation of psychosomatic ophthalmology.

Citing Articles

Telerehabilitation for visual field defects with a multisensory training: a feasibility study.

Bolognini N, Diana L, Rossetti A, Melzi L, Basso G, Manzo V J Neuroeng Rehabil. 2025; 22(1):34.

PMID: 39994637 PMC: 11849177. DOI: 10.1186/s12984-025-01573-4.


Eye yoga for glaucoma: recovery of vascular dysregulation and visual field function-a randomized controlled trial.

Zhou W, Fricke L, Sabel B EPMA J. 2025; 16(1):37-49.

PMID: 39991099 PMC: 11842685. DOI: 10.1007/s13167-024-00389-x.


Blinded by the Mind: Exploring the Hidden Psychiatric Burden in Glaucoma Patients.

Jesus J, Ambrosio J, Meira D, Rodriguez-Una I, Beirao J Biomedicines. 2025; 13(1).

PMID: 39857700 PMC: 11763043. DOI: 10.3390/biomedicines13010116.


[Stress and other risk factors in central serous chorioretinopathy-A myth?].

Hufnagel H, Lahmann C, Pauleikhoff L, Lange C Ophthalmologie. 2025; 122(3):162-169.

PMID: 39820495 DOI: 10.1007/s00347-024-02179-2.


Risk of depression in glaucoma patients with vision impairment: A nationwide cohort study.

Wang S, Jung Y, Han K, Ohn K, Park H, Park C Heliyon. 2025; 11(1):e40617.

PMID: 39758387 PMC: 11699410. DOI: 10.1016/j.heliyon.2024.e40617.


References
1.
Diniz-Filho A, Abe R, Cho H, Baig S, Gracitelli C, Medeiros F . Fast Visual Field Progression Is Associated with Depressive Symptoms in Patients with Glaucoma. Ophthalmology. 2016; 123(4):754-9. PMC: 5758048. DOI: 10.1016/j.ophtha.2015.12.014. View

2.
Leonard B, Song C . Stress, depression, and the role of cytokines. Adv Exp Med Biol. 1999; 461:251-65. DOI: 10.1007/978-0-585-37970-8_14. View

3.
de Kloet E . Corticosteroids, stress, and aging. Ann N Y Acad Sci. 1992; 663:357-71. DOI: 10.1111/j.1749-6632.1992.tb38679.x. View

4.
Bittner A, Ibrahim M, Haythornthwaite J, Diener-West M, Dagnelie G . Vision test variability in retinitis pigmentosa and psychosocial factors. Optom Vis Sci. 2011; 88(12):1496-506. PMC: 3223543. DOI: 10.1097/OPX.0b013e3182348d0b. View

5.
Weinstein P, Dobossy M . [The psychosomatic factors in ophthalmology (author's transl)]. Klin Monbl Augenheilkd. 1975; 166(4):537-9. View